HUMAN POSITRON EMISSION TOMOGRAPHIC [F-18] FLUORODOPA STUDIES CORRELATE WITH DOPAMINE CELL COUNTS AND LEVELS

被引:292
作者
SNOW, BJ
TOOYAMA, I
MCGEER, EG
YAMADA, T
CALNE, DB
TAKAHASHI, H
KIMURA, H
机构
[1] UNIV BRITISH COLUMBIA,KINSMEN LAB NEUROL RES,2255 WESBROOK MALL,VANCOUVER V6T 1Z3,BC,CANADA
[2] UNIV BRITISH COLUMBIA,CTR NEURODEGENERAT DISORDERS,VANCOUVER V6T 1Z3,BC,CANADA
[3] SHIGA UNIV MED SCI,INST MOLEC NEUROBIOL,OTSU,SHIGA 52021,JAPAN
关键词
D O I
10.1002/ana.410340304
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Postmortem counts of dopaminergic cell densities in the substantia nigra (5 subjects) and striatal levels of dopamine (DA) and its metabolites (6 subjects) were determined on 1 parkinsonian (PD), 3 progressive supranuclear palsy (PSP), 1 amyotrophic lateral sclerosis, and 1 Alzheimer's case who had been positron emission tomography scanned with 6-[F-18]fluorodopa during life. [F-18]Fluorodopa uptake rate constants, which presumably depend on the number of functioning striatal DA terminals, were strictly proportional to cell densities (significant correlation with zero intercept) and also correlated significantly with striatal DA levels but with an intercept indicating greater losses of DA than of terminals in PSP and PD. Postmortem data on 6 PD, 1 PSP, and 9 neuronally normal controls substantiated the significant correlation between cell counts and DA levels, with the latter being the more depressed in pathological cases.
引用
收藏
页码:324 / 330
页数:7
相关论文
共 27 条
  • [1] 6-[F-18]FLUORO-L-DOPA PROBES DOPAMINE TURNOVER RATES IN CENTRAL DOPAMINERGIC STRUCTURES
    BARRIO, JR
    HUANG, SC
    MELEGA, WP
    YU, DC
    HOFFMAN, JM
    SCHNEIDER, JS
    SATYAMURTHY, N
    MAZZIOTTA, JC
    PHELPS, ME
    [J]. JOURNAL OF NEUROSCIENCE RESEARCH, 1990, 27 (04) : 487 - 493
  • [2] BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5
  • [3] POSITRON EMISSION TOMOGRAPHY IN PROGRESSIVE SUPRANUCLEAR PALSY
    BHATT, MH
    SNOW, BJ
    MARTIN, WRW
    PEPPARD, R
    CALNE, DB
    [J]. ARCHIVES OF NEUROLOGY, 1991, 48 (04) : 389 - 391
  • [4] DIFFERING PATTERNS OF STRIATAL F-18 DOPA UPTAKE IN PARKINSONS-DISEASE, MULTIPLE SYSTEM ATROPHY, AND PROGRESSIVE SUPRANUCLEAR PALSY
    BROOKS, DJ
    IBANEZ, V
    SAWLE, GV
    QUINN, N
    LEES, AJ
    MATHIAS, CJ
    BANNISTER, R
    MARSDEN, CD
    FRACKOWIAK, RSJ
    [J]. ANNALS OF NEUROLOGY, 1990, 28 (04) : 547 - 555
  • [5] CHIUEH CC, 1986, MPTP NEUROTOXIN PROD, P324
  • [6] CORDES M, 1992, Journal of Nuclear Medicine, V33, P964
  • [7] KINETICS OF INVITRO DECARBOXYLATION AND THE INVIVO METABOLISM OF 2-F-18-FLUORODOPA AND 6-F-18-FLUORODOPA IN THE HOODED RAT
    CUMMING, P
    HAUSSER, M
    MARTIN, WRW
    GRIERSON, J
    ADAM, MJ
    RUTH, TJ
    MCGEER, EG
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (02) : 247 - 250
  • [8] EFFECTS OF TRANSIENT FOREBRAIN ISCHEMIA AND PARGYLINE ON EXTRACELLULAR CONCENTRATIONS OF DOPAMINE, SEROTONIN, AND THEIR METABOLITES IN THE RAT STRIATUM AS DETERMINED BY INVIVO MICRODIALYSIS
    DAMSMA, G
    BOISVERT, DP
    MUDRICK, LA
    WENKSTERN, D
    FIBIGER, HC
    [J]. JOURNAL OF NEUROCHEMISTRY, 1990, 54 (03) : 801 - 808
  • [9] THE METABOLIC ANATOMY OF PARKINSONS-DISEASE - COMPLEMENTARY [F-18] FLUORODEOXYGLUCOSE AND [F-18] FLUORODOPA POSITRON EMISSION TOMOGRAPHIC STUDIES
    EIDELBERG, D
    MOELLER, JR
    DHAWAN, V
    SIDTIS, JJ
    GINOS, JZ
    STROTHER, SC
    CEDARBAUM, J
    GREENE, P
    FAHN, S
    ROTTENBERG, DA
    [J]. MOVEMENT DISORDERS, 1990, 5 (03) : 203 - 213
  • [10] CEREBRAL METABOLISM OF 6-[F-18]FLUORO-L-3,4-DIHYDROXYPHENYLALANINE IN THE PRIMATE
    FIRNAU, G
    SOOD, S
    CHIRAKAL, R
    NAHMIAS, C
    GARNETT, ES
    [J]. JOURNAL OF NEUROCHEMISTRY, 1987, 48 (04) : 1077 - 1082